Azilsartan medoxomil and chlorthalidone
Sponsors
Takeda
Conditions
Essential HypertensionHypertensionSafety
Phase 3
Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
CompletedNCT00591773
Start: 2007-09-30End: 2009-03-31Updated: 2011-04-19
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension
CompletedNCT00818883
Start: 2009-02-28End: 2009-11-30Updated: 2012-02-07
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
CompletedNCT00846365
Start: 2009-03-31End: 2010-06-30Updated: 2012-03-13
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe Hypertension
CompletedNCT00847626
Start: 2009-01-31End: 2010-07-31Updated: 2012-02-07
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
CompletedNCT00996281
Start: 2009-10-31End: 2011-11-30Updated: 2012-11-12
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
CompletedNCT01033071
Start: 2010-01-31End: 2010-11-30Updated: 2012-02-07
Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney Disease
CompletedNCT01309828
Start: 2011-03-31End: 2012-10-31Updated: 2013-12-13